Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decrease in glucose-stimulated insulin secretion following exposure to magnetic fields.

Tomonori Sakurai1, Shin Koyama, Yoshiki Komatsubara

  • 1Department of Radiological Technology, School of Health Sciences, Faculty of Medicine, Hirosaki University, Hirosaki, Japan.

Biochemical and Biophysical Research Communications
|May 18, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A temporal map of B cell diversification mechanisms in mice.

Nature immunology·2026
Same author

Integrated transcriptomic and phenotypic analysis reveals the multi-target antibacterial mechanism of sulforaphane against Xanthomonas oryzae pv. oryzicola.

Pesticide biochemistry and physiology·2026
Same author

Percutaneous versus laparoscopic catheter placement for peritoneal dialysis: a meta-analysis.

BMC nephrology·2025
Same author

Joint Dynamic Brain Network Estimation and Graph Representation Learning for the Recognition of Neurological Disorders.

IEEE journal of biomedical and health informatics·2025
Same author

Association between lipid accumulation product and cognitive impairment: a community-based 4-year prospective cohort study.

Aging clinical and experimental research·2025
Same author

Mathematical Modelling and Uncertainty Quantification for Analysis of Biphasic Coral Reef Recovery Patterns.

Bulletin of mathematical biology·2025

Extremely low frequency magnetic fields (ELFMF) inhibit insulin secretion by impacting cellular energy, calcium, and membrane potential in pancreatic cells. This suggests ELFMF could be a novel approach for controlling insulin release.

Area of Science:

  • Biophysics
  • Cell Biology
  • Endocrinology

Background:

  • Pancreatic beta cells regulate insulin secretion in response to glucose.
  • Understanding cellular mechanisms controlling insulin release is crucial for metabolic disease management.
  • Exploring novel non-pharmacological interventions for modulating insulin secretion is of significant interest.

Purpose of the Study:

  • To investigate the impact of extremely low frequency magnetic field (ELFMF) on glucose-stimulated insulin secretion (GSIS).
  • To elucidate the underlying cellular mechanisms by which ELFMF affects insulin secretion.
  • To assess the potential clinical applicability of ELFMF for modulating insulin secretion.

Main Methods:

  • Utilized HIT-T15 pancreatic beta cells for in vitro experiments.

Related Experiment Videos

  • Exposed cells to a 5 milliTesla (mT) ELFMF.
  • Measured glucose-stimulated insulin secretion, cellular adenosine triphosphate/adenosine diphosphate ratios, membrane potential, cytosolic free calcium ion concentration, and insulin mRNA expression.
  • Assessed cell viability post-exposure.

    • Main Results:

    • Exposure to 5mT ELFMF significantly decreased glucose-stimulated insulin secretion.
    • ELFMF exposure prevented the normal increases in cellular ATP/ADP, membrane depolarization, and cytosolic free calcium ions induced by glucose.
    • Glucose-induced insulin mRNA expression was attenuated by ELFMF, while cell viability remained unaffected.

    Conclusions:

    • Extremely low frequency magnetic fields inhibit GSIS by disrupting key intracellular signaling pathways.
    • ELFMF interferes with energy metabolism, membrane potential regulation, and calcium signaling necessary for insulin secretion.
    • ELFMF shows potential as a novel therapeutic strategy for inhibiting insulin secretion in clinical settings.